Protein Corona over Mesoporous Silica Nanoparticles: Influence of the Pore Diameter on Competitive Adsorption and Application to Prostate Cancer Diagnostics

Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Vidaurre-Agut, C
- Rivero-Buceta, E
- Romani-Cubells, E
- Clemments, AM
- Landry, CC
- Botella, P
Grupos
Abstract
Diagnostic tests based on proteomics analysis can have significant advantages over more traditional biochemical tests. However, low molecular weight (MW) protein biomarkers are difficult to identify by standard mass spectrometric analysis, as they are usually present at low concentrations and are masked by more abundant resident proteins. We have previously shown that mesoporous silica nanoparticles are able to capture a predominantly low MW protein fraction from the serum, as compared to the protein corona (PC) adsorbed onto dense silica nanoparticles. In this study, we begin by further investigating this effect using liquid chromatography-mass spectrometry (LC-MS)/MS and thermogravimetric analysis (TGA) to compare the MW of the proteins in the coronas of mesoporous silica nanoparticles with the same particle size but different pore diameters. Next, we examine the process by which two proteins, one small and one large, adsorb onto these mesoporous silica nanoparticles to establish a theory of why the corona becomes enriched in low MW proteins. Finally, we use this information to develop a novel system for the diagnosis of prostate cancer. An elastic net statistical model was applied to LC-MS/MS protein coronas from the serum of 22 cancer patients, identifying proteins specific to each patient group. These studies help to explain why low MW proteins predominate in the coronas of mesoporous silica nanoparticles, and they illustrate the ability of this information to supplement more traditional diagnostic tests.
Datos de la publicación
- ISSN/ISSNe:
- 2470-1343, 2470-1343
- Tipo:
- Article
- Páginas:
- 8852-8861
- PubMed:
- 31459973
- Factor de Impacto:
- 0,767 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
Acs Omega AMER CHEMICAL SOC
Citas Recibidas en Web of Science: 27
Documentos
- No hay documentos
Filiaciones
Proyectos y Estudios Clínicos
PROSPET. DISPOSITIVO MULTI-IMAGEN CON UN DETECTOR PET PARA GUIAR LA BIOPSIA, EL TRATAMIENTO Y EL SEGUIMIENTO DEL CÁNCER DE PRÓSTATA.
Investigador Principal: CÉSAR DAVID VERA DONOSO
DTS15/00044 . INSTITUTO DE SALUD CARLOS III . 2016
NUEVOS MÉTODOS DIAGNÓSTICOS Y PRONÓSTICOS DEL CÁNCER Y SUS COMPLICACIONES TROMBÓTICAS (DIPROCAT).
Investigador Principal: PILAR MEDINA BADENES
PI17/00495 . INSTITUTO DE SALUD CARLOS III . 2018
Teracap. teranostica de precisión en el cáncer de próstata.
Investigador Principal: JOSÉ MARÍA BENLLOCH BAVIERA
GV/2017 . 2018
ESTUDIO OBSERVACIONAL PARA DESCRIBIR RETROSPECTIVAMENTE LA EVOLUCIÓN DE LOS PACIENTES CON CÁNCER DE PRÓSTATA A LO LARGO DE LA ENFERMEDAD A TRAVÉS DE LA REUTILIZACIÓN DE LOS REGISTROS ELECTRÓNICOS DE SALUD CON INTELIGENCIA ARTIFICIAL. ESTUDIO OVERVIEW.
Investigador Principal: ANTONIO CONDE MORENO
JAN-CPR-2018-01 . 2018
ESTUDIO OBSERVACIONAL TRANSVERSAL PARA DESCRIBIR LA PREVALENCIA E INTENSIDAD DE LA FATIGA EN PACIENTES CON CÁNCER DE PRÓSTATA RESISTENTE A LA CASTRACIÓN EN ESPAÑA.
Investigador Principal: CÉSAR DAVID VERA DONOSO
JAN-CPR-2014-01 . 2015
Cita
Vidaurre C,Rivero E,Romani E,Clemments AM,VERA CD,Landry CC,Botella P. Protein Corona over Mesoporous Silica Nanoparticles: Influence of the Pore Diameter on Competitive Adsorption and Application to Prostate Cancer Diagnostics. Acs Omega. 2019. 4. (5):p. 8852-8861. IF:2,870. (2).